Journal for ImmunoTherapy of Cancer (Nov 2021)

547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma

  • Andrew Haydon,
  • Celeste Lebbe,
  • Jose Lutzky,
  • Gregory Daniels,
  • Ragini Kudchadkar,
  • Ann Silk,
  • Nikhil Khushalani,
  • Frances Collichio,
  • Jean-Jaques Grob,
  • Samantha Bowyer,
  • Praveen Bommareddy,
  • Andrew Hill,
  • Danny Rischin,
  • Daniel Brungs,
  • Michael Migden,
  • Matthew Fury,
  • Jenny Lee,
  • Muhammad Alamgeer,
  • Dimitrios Colevas,
  • Wanxing Chai-Ho,
  • Piyush Sheladia,
  • Shui He,
  • Claudia Andreu-Vieyra

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.547
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.